Abdul-Fattah Ahmad M, Truong-Le Vu, Yee Luisa, Pan Emilie, Ao Yi, Kalonia Devendra S, Pikal Michael J
Department of Pharmaceutical Sciences, University of Connecticut, Storrs, CT 06269, USA.
Pharm Res. 2007 Apr;24(4):715-27. doi: 10.1007/s11095-006-9191-2. Epub 2007 Feb 15.
To investigate the impact of drying method on the storage stability of dried vaccine formulations.
A sucrose-based formulation of a live attenuated virus vaccine of a parainfluenza strain, with and without surfactant, was dried from by different methods; freeze drying, spray drying and foam drying. Dried powders were characterized by differential scanning calorimetry, specific surface area (SSA) analysis and by electron spectroscopy for chemical analysis (ESCA) to evaluate vaccine surface coverage in the dried formulations. Dried formulations were subjected to storage stability studies at 4, 25 and 37 degrees C. The vaccine was assayed initially and at different time points to measure virus-cell infectivity, and the degradation rate constant of the vaccine in different dried preparations was determined.
SSA was highest with the spray dried preparation without surfactant (approximately 2.8 m(2)/g) and lowest in the foam dried preparations (with or without surfactant) (approximately 0.1 m(2)/g). Vaccine surface coverage was estimated based on ESCA measurements of nitrogen content. It was predicted to be highest in the spray dried preparation without surfactant and lowest in the foam with surfactant. Stability studies conducted at 25 degrees C and 37 degrees C showed that the vaccine was most stable in the foam dried preparation with surfactant and least stable in spray dried preparations without surfactant and in all freeze dried preparations regardless of the presence of surfactant. Addition of surfactant did lower the SSA and vaccine surface coverage in freeze dried preparations but still did not improve storage stability.
In drying methods that did not involve a freezing step, good storage stability of Medi 534 vaccine in the dried form was found with low SSA and low vaccine surface accumulation, both of which integrate into low fraction of vaccine at the surface. Ice appears to be a major destabilizing influence.
研究干燥方法对冻干疫苗制剂储存稳定性的影响。
一种基于蔗糖的副流感毒株减毒活病毒疫苗制剂,添加或不添加表面活性剂,采用不同方法进行干燥;冷冻干燥、喷雾干燥和泡沫干燥。通过差示扫描量热法、比表面积(SSA)分析以及化学分析电子能谱(ESCA)对干燥粉末进行表征,以评估干燥制剂中疫苗的表面覆盖率。将干燥制剂在4℃、25℃和37℃下进行储存稳定性研究。在初始及不同时间点对疫苗进行检测,以测量病毒 - 细胞感染性,并确定不同干燥制剂中疫苗的降解速率常数。
不添加表面活性剂的喷雾干燥制剂的SSA最高(约2.8 m²/g),而泡沫干燥制剂(添加或不添加表面活性剂)的SSA最低(约0.1 m²/g)。基于氮含量的ESCA测量估算疫苗表面覆盖率。预计不添加表面活性剂的喷雾干燥制剂中疫苗表面覆盖率最高,而添加表面活性剂的泡沫制剂中最低。在25℃和37℃进行的稳定性研究表明,添加表面活性剂的泡沫干燥制剂中疫苗最稳定,不添加表面活性剂的喷雾干燥制剂以及所有冷冻干燥制剂(无论是否添加表面活性剂)中疫苗最不稳定。添加表面活性剂确实降低了冷冻干燥制剂的SSA和疫苗表面覆盖率,但仍未改善储存稳定性。
在不涉及冷冻步骤的干燥方法中,发现Medi 534疫苗冻干形式具有良好的储存稳定性,其SSA低且疫苗表面积累少,这两者均导致表面疫苗比例低。冰似乎是主要的不稳定因素。